| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
|
Eertink, J. J.
|
|
|
49 |
3 |
p. 943-952
|
article
|
| 2 |
Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting
|
Johnsson, Kerstin
|
|
|
49 |
3 |
p. 1041-1051
|
article
|
| 3 |
An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients
|
Wallis, David
|
|
|
49 |
3 |
p. 881-888
|
article
|
| 4 |
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
|
Yang, Shan-Shan
|
|
|
49 |
3 |
p. 980-991
|
article
|
| 5 |
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer
|
Morawitz, Janna
|
|
|
49 |
3 |
p. 992-1001
|
article
|
| 6 |
Decrease in the cortex/striatum metabolic ratio on [18F]-FDG PET: a biomarker of autoimmune encephalitis
|
De Leiris, Nicolas
|
|
|
49 |
3 |
p. 921-931
|
article
|
| 7 |
Eribulin improves tumor oxygenation demonstrated by 18F-DiFA hypoxia imaging, leading to radio-sensitization in human cancer xenograft models
|
Bo, Tomoki
|
|
|
49 |
3 |
p. 821-833
|
article
|
| 8 |
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
|
Eertink, Jakoba J.
|
|
|
49 |
3 |
p. 932-942
|
article
|
| 9 |
2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS
|
Paccagnella, Andrea
|
|
|
49 |
3 |
p. 1090-1091
|
article
|
| 10 |
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies
|
Cohen, Dan
|
|
|
49 |
3 |
p. 953-962
|
article
|
| 11 |
Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model
|
Liu, Yuwei
|
|
|
49 |
3 |
p. 871-880
|
article
|
| 12 |
Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies
|
Amadeo, Francesco
|
|
|
49 |
3 |
p. 796-808
|
article
|
| 13 |
68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent
|
Duan, Xiaojiang
|
|
|
49 |
3 |
p. 1030-1040
|
article
|
| 14 |
68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement
|
Chavoshi, Mohammadreza
|
|
|
49 |
3 |
p. 1021-1029
|
article
|
| 15 |
Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients
|
Wang, Guochang
|
|
|
49 |
3 |
p. 1052-1062
|
article
|
| 16 |
High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma
|
Hotta, Masatoshi
|
|
|
49 |
3 |
p. 1088-1089
|
article
|
| 17 |
ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
|
Chen, Weiyu
|
|
|
49 |
3 |
p. 861-870
|
article
|
| 18 |
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer
|
Anconina, Reut
|
|
|
49 |
3 |
p. 1012-1020
|
article
|
| 19 |
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
|
Tian, Mei
|
|
|
49 |
3 |
p. 895-904
|
article
|
| 20 |
Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience
|
Tan, Hui
|
|
|
49 |
3 |
p. 1002-1011
|
article
|
| 21 |
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)
|
Khreish, Fadi
|
|
|
49 |
3 |
p. 1075-1085
|
article
|
| 22 |
Myocardial perfusion SPECT findings in postCOVID period
|
Araz, Mine
|
|
|
49 |
3 |
p. 889-894
|
article
|
| 23 |
Noninvasive assessment of coronary microvascular dysfunction using SPECT myocardial perfusion imaging and myocardial perfusion entropy quantification in a rodent model of type 2 diabetes
|
Carabelli, Adrien
|
|
|
49 |
3 |
p. 809-820
|
article
|
| 24 |
Patients’ findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT
|
Sollini, Martina
|
|
|
49 |
3 |
p. 791-795
|
article
|
| 25 |
Peripheral inflammation is associated with brain SPECT perfusion changes in schizophrenia
|
Fond, Guillaume
|
|
|
49 |
3 |
p. 905-912
|
article
|
| 26 |
RGD-functionalised melanin nanoparticles for intraoperative photoacoustic imaging-guided breast cancer surgery
|
Liu, Jing-Jing
|
|
|
49 |
3 |
p. 847-860
|
article
|
| 27 |
Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series
|
Morand, Aurelie
|
|
|
49 |
3 |
p. 913-920
|
article
|
| 28 |
The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDG
|
Lan, Lianjun
|
|
|
49 |
3 |
p. 963-979
|
article
|
| 29 |
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)
|
Bauckneht, Matteo
|
|
|
49 |
3 |
p. 1063-1074
|
article
|
| 30 |
Two experts and a newbie: [18F]PARPi vs [18F]FTT vs [18F]FPyPARP—a comparison of PARP imaging agents
|
Stotz, Sophie
|
|
|
49 |
3 |
p. 834-846
|
article
|
| 31 |
Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?
|
Schierz, Jan-Henning
|
|
|
49 |
3 |
p. 1086-1087
|
article
|
Journal description